Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Birth control pills can help reduce mild to moderate acne in women.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.